-
effectivehealthcare.ahrq.gov/products/colorectal-cancer-liver-metastases-therapies/research-protocol
January 31, 2012 - can be completely resected with negative margins, two adjacent liver segments can be spared, adequate vascular
-
effectivehealthcare.ahrq.gov/products/venous-ulcers-treatment-future/research
-
effectivehealthcare.ahrq.gov/products/menopause/research-protocol
April 03, 2012 - Current Page Topic Timeline Sep. 19, 2011 Topic Initiated Apr. 3, 2012 Research Protocol Mar. 5, 2015 Systematic Review Jul. 30, 2015 Disposition of Comments Report Menopausal Symptoms: Comparative Effectiveness Review of Therapies
Research Protocol Archived April 3, 2012 Download Main Document PDF 662.5 KB
…
-
effectivehealthcare.ahrq.gov/products/sodium-potassium/research-protocol
March 01, 2017 - Current Page Topic Timeline Aug. 30, 2016 Topic Initiated Mar. 1, 2017 Research Protocol Jun. 21, 2018 Systematic Review Effects of Dietary Sodium and Potassium Intake on Chronic Disease Outcomes and Related Risk Factors
Research Protocol March 1, 2017 Download Main Document PDF 1.1 MB
This research p…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
January 01, 2007 - The renin system is an
important mediator of blood volume, arterial pressure, and cardiac and vascular … Angiotensin II acts directly on the resistance
vessels to increase systemic vascular resistance and … events [including stroke], symptomatic coronary artery disease, end stage renal disease, peripheral
vascular … Angiotensin II acts directly on the resistance vessels to increase systemic vascular resistance and … events [including stroke], symptomatic coronary artery disease, end-stage renal disease, peripheral
vascular
-
effectivehealthcare.ahrq.gov/products/lysosomal-storage-diseases-therapies/technical-brief
January 02, 2013 - Current Page Topic Timeline Oct. 4, 2011 Topic Initiated Oct. 5, 2011 Research Protocol Jan. 2, 2013 Technical Brief May. 2, 2013 Disposition of Comments Report Enzyme-Replacement Therapies for Lysosomal Storage Diseases
Technical Brief Archived January 2, 2013 Web Version [NLM Site] Download Main Document PDF 912…
-
effectivehealthcare.ahrq.gov/products/vitamin-d-calcium/research-protocol
June 10, 2013 - Outcomes
CVD clinical outcomes
Cardiac events or symptoms
Cerebrovascular events
Peripheral vascular … myocardial infarction, angina]; cerebrovascular events [stroke; transient ischemic attacks]; peripheral vascular
-
effectivehealthcare.ahrq.gov/products/coronary-stents-outcomes/research
February 10, 2010 - Eisenstein: Research support from Medtronic Vascular and Eli Lilly
Ghazala Haque: None
David Dai: None … 0.001
22.8
23.0
NS
Insulin
20430 (9.4%)
4533 (10.1%)
<0.001
9.5
9.6
NS
Peripheral Vascular
-
effectivehealthcare.ahrq.gov/products/renal-artery-stenosis/research-2007/
-
effectivehealthcare.ahrq.gov/products/coronary-artery-stenting/research
February 26, 2013 - Current Page Topic Timeline Jun. 25, 2010 Topic Suggestion Aug. 29, 2011 Research Protocol Feb. 26, 2013 Systematic Review Jul. 3, 2013 Disposition of Comments Report Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Artery Stenting: Comparative Effectiveness Review
Sys…
-
effectivehealthcare.ahrq.gov/products/high-cholestorol-medications/research
September 01, 2009 - Current Page Topic Timeline Jan. 1, 2005 Topic Initiated Sep. 1, 2009 Systematic Review Jun. 11, 2013 Surveillance Report Comparative Effectiveness of Lipid-Modifying Agents
Systematic Review Archived September 1, 2009 Web Version [NLM Site] Download Main Document PDF 1.1 MB
Related Files Download Re…
-
effectivehealthcare.ahrq.gov/products/high-cholestorol-medicines-update/research/
-
effectivehealthcare.ahrq.gov/products/renal-update/research/
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pbt-lsr-draft-ets-obs.xlsx
March 15, 2022 - 0.32 to 0.71)
Psychiatric disorders: 4.2% (14/337) vs. 14.8% (50/337), RR 0.28 (95% CI 0.16 to 0.50)
Vascular
-
effectivehealthcare.ahrq.gov/products/uterine-fibroids/research-protocol
February 29, 2016 - treatment effectiveness differ by patient or fibroid characteristics (e.g., age, race/ethnicity; symptoms; vascular … fibroid characteristics (e.g., age; race/ethnicity; symptoms; menopausal status; imaging characteristics; vascular
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/uterine-fibroids_research-protocol.pdf
March 01, 2016 - treatment effectiveness differ by patient or fibroid characteristics
(e.g., age, race/ethnicity; symptoms; vascular … characteristics (e.g., age; race/ethnicity; symptoms; menopausal status; imaging
characteristics; vascular
-
effectivehealthcare.ahrq.gov/products/coronary-artery-stenting/research-protocol
August 29, 2011 - elastography.af.
1,307
21
thermography.af.
6,794
22
microcirculatory resistance.af.
32
23
vascular
-
effectivehealthcare.ahrq.gov/products/measuring-blood-pressure-future/research
-
effectivehealthcare.ahrq.gov/products/atrial-fibrillation/research
June 28, 2013 - Current Page Topic Timeline Sep. 27, 2011 Topic Initiated Jan. 27, 2012 Research Protocol Jun. 28, 2013 Systematic Review Nov. 5, 2013 Disposition of Comments Report Treatment of Atrial Fibrillation
Systematic Review Archived June 28, 2013 Web Version [NLM Site] Download Main Document PDF 3.9 MB
Rela…
-
effectivehealthcare.ahrq.gov/products/atrial-fibrillation/research-protocol
January 27, 2012 - Current Page Topic Timeline Sep. 27, 2011 Topic Initiated Jan. 27, 2012 Research Protocol Jun. 28, 2013 Systematic Review Nov. 5, 2013 Disposition of Comments Report Treatment of Atrial Fibrillation
Research Protocol Archived January 27, 2012 Download Main Document PDF 343.6 KB
On May 22, 2011, sever…